PEOPLE - Orchid Biocomputer (US) makes appointment:
This article was originally published in Clinica
Orchid Biocomputer, a US developer of lab-on-the-chip products, has elected Anne VanLent to its board of directors. Ms VanLent is vice-president of ventures at Sarnoff, a New Jersey-based innovative technology company.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.